EUVIMEDEUVIMED entdecken
Studienprotokoll

Implementation of a protocol for postcesarean delivery oral cephalexin and metronidazole to prevent surgical site infection in patients with BMI≥30 kg/m2

Jade Denninger, Kathryn McNeil, Michael Herman, Alexander Bos, Katharine Wilson, Alexandra Herman

Journal of the American Pharmacists Association · 2026

DOI: 10.1016/j.japh.2025.102936 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Journal of the American Pharmacists Association, 2026. Verfasst von Jade Denninger und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cephalexin, Metronidazole, Surgical Wound Infection, Cesarean Section. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cesarean-section surgical site infections (SSIs) are the leading cause of postcesarean complications. Few studies have examined postcesarean antibiotic prophylaxis in patients with obesity (Body mass index >30 kg/m2 or greater) in a real-world setting. OBJECTIVES: The aim of this study was to evaluate the implementation of a postcesarean oral cephalexin and metronidazole antibiotic prophylaxis protocol for patients with obesity, describe clinical outcomes in these patients, and describe the pharmacist's role in protocol implementation. METHODS: An interdisciplinary team, including a pharmacist, developed this protocol for post-cesarean antibiotic prophylaxis. The pharmacist later implemented the order sets and screened patients to recommend prophylaxis. We conducted a single center, retrospective cohort study comparing SSI outcomes of patients with obesity at 60-days who received 48-hours of antibiotic prophylaxis with oral cephalexin and metronidazole to patients who received standard of care. RESULTS: Of 397 patients, 202 received 48-hour antibiotic prophylaxis, 41 received partial antibiotic prophylaxis, and 154 did not receive postcesarean antibiotic prophylaxis in addition to standard of care. At 60 days postcesarean, SSIs were significantly lower in the 48-hour prophylaxis group compared to standard of care (7.9% vs. 11%, P = 0.004). There was not a significant reduction in SSIs (9.4% vs. 11%, P = 0.114) when including patients who received partial antibiotic prophylaxis. Higher BMI was associated with an increased risk of infection. When controlling for BMI, patients not receiving prophylactic antibiotics had an increased incidence of SSI (adjusted OR = 2.62, 95% CI; 1.122-6.132). There were no hospital readmissions for patients who received prophylaxis compared to 3.2% (n = 5) patients who did not. CONCLUSION: Postcesarean antibiotic prophylaxis with oral cephalexin and metronidazole for 48 h in patients with obesity was associated with reduced incidence of SSI within 60 day follow up. Pharmacists play a key role in the implementation of protocols which can improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CephalexinMetronidazoleSurgical Wound InfectionCesarean SectionAnti-Bacterial AgentsAntibiotic ProphylaxisObesityHumansFemaleRetrospective StudiesAdultPregnancyBody Mass IndexAdministration, OralPharmacistsCohort StudiesClinical Protocols

Substanzen

CephalexinMetronidazoleAnti-Bacterial Agents

Zitieren

APA

Denninger, J., McNeil, K., Herman, M., Bos, A., Wilson, K., & Herman, A. (2026). Implementation of a protocol for postcesarean delivery oral cephalexin and metronidazole to prevent surgical site infection in patients with BMI≥30 kg/m2. Journal of the American Pharmacists Association. https://doi.org/10.1016/j.japh.2025.102936

Vancouver

Denninger J, McNeil K, Herman M, Bos A, Wilson K, Herman A. Implementation of a protocol for postcesarean delivery oral cephalexin and metronidazole to prevent surgical site infection in patients with BMI≥30 kg/m2. Journal of the American Pharmacists Association. 2026. doi:10.1016/j.japh.2025.102936

BibTeX
@article{Denninger2026,
  author = {Denninger, Jade and McNeil, Kathryn and Herman, Michael and Bos, Alexander and Wilson, Katharine and Herman, Alexandra},
  title = {Implementation of a protocol for postcesarean delivery oral cephalexin and metronidazole to prevent surgical site infection in patients with BMI≥30 kg/m2},
  journal = {Journal of the American Pharmacists Association},
  year = {2026},
  doi = {10.1016/j.japh.2025.102936}
}
Kostenlos starten →